Drug Eluting Balloon Market (Product: Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others; and Technology: Paccocath, FreePac, TransPax, EnduraCoat, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast,

Drug Eluting Balloon Market (Product: Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others; and Technology: Paccocath, FreePac, TransPax, EnduraCoat, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Drug Eluting Balloon Market – Scope of Report

TMR’s report on the global drug eluting balloon market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global drug eluting balloon market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug eluting balloon market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the drug eluting balloon market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug eluting balloon market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug eluting balloon market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug eluting balloon market.

The report delves into the competitive landscape of the global drug eluting balloon market. Key players operating in the global drug eluting balloon market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug eluting balloon market profiled in this report.

Key Questions Answered in Global drug eluting balloon Market Report
  • What is the sales/revenue generated by drug eluting balloon across all regions during the forecast period?
  • What are the opportunities in the global drug eluting balloon market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Drug Eluting Balloon Market – Research Objectives and Research Approach

The comprehensive report on the global drug eluting balloon market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug eluting balloon market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug eluting balloon market.


1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug Eluting Balloon Market
4. Market Overview
4.1. Market Segmentation
  4.1.1. Segment Definition
  4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6. Drug Eluting Balloon Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2023-2031
  6.3.1. Coronary Drug Eluting Balloon
  6.3.2. Peripheral Drug Eluting Balloon
  6.3.3. Others
6.4. Market Attractiveness, by Product
7. Drug Eluting Balloon Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2023-2031
  7.3.1. Paccocath
  7.3.2. FreePac
  7.3.3. TransPax
  7.3.4. EnduraCoat
  7.3.5. Others
7.4. Market Attractiveness, by Technology
8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2023-2031
  8.3.1. Hospitals and Ambulatory Surgery Centers
  8.3.2. Cath Labs
  8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2023-2031
  9.2.1. North America
  9.2.2. Europe
  9.2.3. Asia Pacific
  9.2.4. Latin America
  9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Drug Eluting Balloon Market Analysis and Forecast
10.1. Introduction
  10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2023-2031
  10.2.1. Coronary Drug Eluting Balloon
  10.2.2. Peripheral Drug Eluting Balloon
  10.2.3. Others
10.3. Market Attractiveness, by Product
10.4. Market Value Forecast, by Technology, 2023-2031
  10.4.1. Paccocath
  10.4.2. FreePac
  10.4.3. TransPax
  10.4.4. EnduraCoat
  10.4.5. Others
10.5. Market Attractiveness, by Technology
10.6. Market Value Forecast, by End-user, 2023-2031
  10.6.1. Hospitals and Ambulatory Surgery Centers
  10.6.2. Cath Labs
  10.6.3. Others
10.7. Market Attractiveness, by End-user
10.8. Market Value Forecast, by Country, 2023-2031
  10.8.1. U.S.
  10.8.2. Canada
10.9. Market Attractiveness Analysis
  10.9.1. By Product
  10.9.2. By Technology
  10.9.3. By End-user
  10.9.4. By Country
11. Europe Drug Eluting Balloon Market Analysis and Forecast
11.1. Introduction
  11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2023-2031
  11.2.1. Coronary Drug Eluting Balloon
  11.2.2. Peripheral Drug Eluting Balloon
  11.2.3. Others
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Technology, 2023-2031
  11.4.1. Paccocath
  11.4.2. FreePac
  11.4.3. TransPax
  11.4.4. EnduraCoat
  11.4.5. Others
11.5. Market Attractiveness, by Technology
11.6. Market Value Forecast, by End-user, 2023-2031
  11.6.1. Hospitals and Ambulatory Surgery Centers
  11.6.2. Cath Labs
  11.6.3. Others
11.7. Market Attractiveness, by End-user
11.8. Market Value Forecast, by Country/Sub-region, 2023-2031
  11.8.1. Germany
  11.8.2. U.K.
  11.8.3. France
  11.8.4. Italy
  11.8.5. Spain
  11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
  11.9.1. By Product
  11.9.2. By Technology
  11.9.3. By End-user
  11.9.4. By Country/Sub-region
12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast
12.1. Introduction
  12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2023-2031
  12.2.1. Coronary Drug Eluting Balloon
  12.2.2. Peripheral Drug Eluting Balloon
  12.2.3. Others
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Technology, 2023-2031
  12.4.1. Paccocath
  12.4.2. FreePac
  12.4.3. TransPax
  12.4.4. EnduraCoat
  12.4.5. Others
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, by End-user, 2023-2031
  12.6.1. Hospitals and Ambulatory Surgery Centers
  12.6.2. Cath Labs
  12.6.3. Others
12.7. Market Attractiveness, by End-user
12.8. Market Value Forecast, by Country/Sub-region, 2023-2031
  12.8.1. China
  12.8.2. Japan
  12.8.3. India
  12.8.4. Australia & New Zealand
  12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
  12.9.1. By Product
  12.9.2. By Technology
  12.9.3. By End-user
  12.9.4. By Country/Sub-region
13. Latin America Drug Eluting Balloon Market Analysis and Forecast
13.1. Introduction
  13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2023-2031
  13.2.1. Coronary Drug Eluting Balloon
  13.2.2. Peripheral Drug Eluting Balloon
  13.2.3. Others
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Technology, 2023-2031
  13.4.1. Paccocath
  13.4.2. FreePac
  13.4.3. TransPax
  13.4.4. EnduraCoat
  13.4.5. Others
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, by End-user, 2023-2031
  13.6.1. Hospitals and Ambulatory Surgery Centers
  13.6.2. Cath Labs
  13.6.3. Others
13.7. Market Attractiveness, by End-user
13.8. Market Value Forecast, by Country/Sub-region, 2023-2031
  13.8.1. Brazil
  13.8.2. Mexico
  13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
  13.9.1. By Product
  13.9.2. By Technology
  13.9.3. By End-user
  13.9.4. By Country/Sub-region
14. Middle East & Africa Drug Eluting Balloon Market Analysis and Forecast
14.1. Introduction
  14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2023-2031
  14.2.1. Coronary Drug Eluting Balloon
  14.2.2. Peripheral Drug Eluting Balloon
  14.2.3. Others
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Technology, 2023-2031
  14.4.1. Paccocath
  14.4.2. FreePac
  14.4.3. TransPax
  14.4.4. EnduraCoat
  14.4.5. Others
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, by End-user, 2023-2031
  14.6.1. Hospitals and Ambulatory Surgery Centers
  14.6.2. Cath Labs
  14.6.3. Others
14.7. Market Attractiveness, by End-user
14.8. Market Value Forecast, by Country/Sub-region, 2023-2031
  14.8.1. GCC Countries
  14.8.2. South Africa
  14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
  14.9.1. By Product
  14.9.2. By Technology
  14.9.3. By End-user
  14.9.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
  15.3.1. Bayer AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
  15.3.2. Medtronic
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
  15.3.3. B. Braun Melsungen AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
  15.3.4. Cook Medical, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
  15.3.5. Boston Scientific Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
  15.3.6. Becton, Dickson and Company
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
  15.3.7. EuroCor
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
  15.3.8. Terumo Corporation
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
  15.3.9. Koninklijke Philips N.V.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings